{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:55:29Z","timestamp":1792828529589,"version":"4.5.0"},"reference-count":90,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/neuroindia.ni_330_17","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T08:55:50Z","timestamp":1494320150000},"page":"577","source":"Crossref","is-referenced-by-count":20,"title":["Genetics of pituitary adenomas"],"prefix":"10.4103","volume":"65","author":[{"given":"M\u00e1rta","family":"Korbonits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Shaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.205922-1","unstructured":"Boundless. The Anterior Pituitary [Internet]. Boundless Anatomy and Physiology; 2016. Available from: https:\/\/www.boundless.com\/physiology\/textbooks\/boundless-anatomy-and-physiology-textbook\/endocrine-system-16\/the-pituitary-gland-155\/the-posterior-pituitary-787-9333\/. [Last cited on 2016 Oct 29]."},{"key":"key-10.4103\/0028-3886.205922-2","unstructured":"University of Wisconsin. Pituitary Gland-Neuroradiology [Internet]. Department of Radiology. 2011. Available from: https:\/\/sites.google.com\/a\/wisc.edu\/neuroradiology\/anatomy\/under-spin\/slide-1. [Last cited on 2016 Oct 29]."},{"key":"key-10.4103\/0028-3886.205922-3","unstructured":"Kimball J. Hormones of the Pituitary [Internet]. Kimball's Biology Pages. 2015. Available from: http:\/\/users.rcn.com\/jkimball.ma.ultranet\/BiologyPages\/W\/Welcome.html. [Last cited on 2016 Oct 29]."},{"key":"key-10.4103\/0028-3886.205922-4","first-page":"125","volume-title":"Mutations in the homeobox gene HESX1\/Hesx1 associated with septo-optic dysplasia in human and mouse","author":"Dattani","year":"1998","journal-title":"Nat Genet"},{"key":"key-10.4103\/0028-3886.205922-5","first-page":"393","volume-title":"Septo-optic dysplasia","author":"Webb","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"key-10.4103\/0028-3886.205922-6","first-page":"229","volume-title":"Pit-1 and pituitary function","author":"Pf\u00e4ffle","year":"1993","journal-title":"J Pediatr Endocrinol"},{"key":"key-10.4103\/0028-3886.205922-7","unstructured":"de Graaff LC. PROP1-Related Combined Pituitary Hormone Deficiency. GeneReviews(\u00ae). University of Washington, Seattle; 1993 [cited 2017 Jan 22]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20301521"},{"key":"key-10.4103\/0028-3886.205922-8","first-page":"239","volume-title":"Pituitary development: A complex, temporal regulated process dependent on specific transcriptional factors","author":"de","year":"2012","journal-title":"J Endocrinol"},{"key":"key-10.4103\/0028-3886.205922-9","unstructured":"Patil PR, Bharambe BM, Sondankar D. An insight into pituitary fossa lesions: A single institutional experience. Ann Pathol Lab Med 2016;3."},{"key":"key-10.4103\/0028-3886.205922-10","first-page":"35","volume-title":"Diseases of the sella and parasellar region: An overview","author":"Derman","year":"2013","journal-title":"Semin Roentgenol"},{"key":"key-10.4103\/0028-3886.205922-11","first-page":"613","volume-title":"The prevalence of pituitary adenomas: A systematic review","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"key-10.4103\/0028-3886.205922-12","first-page":"4769","volume-title":"High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-13","first-page":"2172","volume-title":"Epidemiology of pituitary adenoma: Results of the first Swiss study","author":"Fontana","year":"2009","journal-title":"Rev Med Suisse"},{"key":"key-10.4103\/0028-3886.205922-14","first-page":"29","volume-title":"The epidemiology of endocrine tumours","author":"Monson","year":"2000","journal-title":"Endocr Relat Cancer"},{"key":"key-10.4103\/0028-3886.205922-15","first-page":"273","volume-title":"Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-16","first-page":"545","volume-title":"Prevalence and incidence of pituitary adenomas: A population based study in Malta","author":"Gruppetta","year":"2013","journal-title":"Pituitary"},{"key":"key-10.4103\/0028-3886.205922-17","first-page":"4268","volume-title":"Incidence of pituitary adenomas in Northern Finland in 1992\u20132007","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-18","first-page":"3","volume-title":"Incidentalomas - A \u201cdisease\u201d of modern imaging technology","author":"Wagner","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-19","first-page":"377","volume-title":"Prevalence of pituitary adenomas: A community-based, cross-sectional study in Banbury (Oxfordshire, UK)","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/0028-3886.205922-20","first-page":"655","volume-title":"The epidemiology of pituitary adenomas in Iceland, 1955-2012: A nationwide population-based study","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0028-3886.205922-21","first-page":"185\u2013217","volume-title":"Transphenoidal microsurgery of the normal and pathological pituitary","author":"Hardy","year":"1969","journal-title":"Clin Neurosurg"},{"key":"key-10.4103\/0028-3886.205922-22","first-page":"131","volume-title":"Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas","author":"Mete","year":"2016","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0028-3886.205922-23","unstructured":"Knipe H, Weerakkody Y. Pituitary Adenoma. Radippaedia. 2016. Available from: http:\/\/radiopaedia.org\/articles\/pituitary-adenoma. [Last cited on 2016 Oct 30]."},{"key":"key-10.4103\/0028-3886.205922-24","first-page":"803","volume-title":"Invasion of the cavernous sinus space in pituitary adenomas: Endoscopic verification and its correlation with an MRI-based classification","author":"Micko","year":"2015","journal-title":"J Neurosurg"},{"key":"key-10.4103\/0028-3886.205922-25","first-page":"203","volume-title":"Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry","author":"Saeger","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0028-3886.205922-26","first-page":"123","volume-title":"A new prognostic clinicopathological classification of pituitary adenomas: A multicentric case\u2013control study of 410 patients with 8 years post-operative follow-up","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol"},{"key":"key-10.4103\/0028-3886.205922-27","unstructured":"J\u00e4hnichen S. GPCR Structure-Function [Internet]. GNU-FDL. 2006. Available from: \u2122-gpcr-structure-function-services-22.htm\">http:\/\/www.creative-biostructure.com\/custom-mempro \u2122-gpcr-structure-function-services-22.htm. [Last cited on 2016 Oct 29]."},{"key":"key-10.4103\/0028-3886.205922-28","first-page":"692","volume-title":"GTPase inhibiting mutations activate the \u03b1 chain of Gs and stimulate adenylyl cyclase in human pituitary tumours","author":"Landis","year":"1989","journal-title":"Nature"},{"key":"key-10.4103\/0028-3886.205922-29","first-page":"891","volume-title":"Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors","author":"Shi","year":"1998","journal-title":"Chin Med J (Engl)"},{"key":"key-10.4103\/0028-3886.205922-30","first-page":"165","volume-title":"Prevalence of gsp oncogene in somatotropinomas and clinically non-functioning pituitary adenomas: Our experience","author":"Taboada","year":"2009","journal-title":"Pituitary"},{"key":"key-10.4103\/0028-3886.205922-31","first-page":"58","volume-title":"An R201H activating mutation of the GNAS1 (Gsalpha) gene in a corticotroph pituitary adenoma","author":"Riminucci","year":"2002","journal-title":"Mol Pathol"},{"key":"key-10.4103\/0028-3886.205922-32","first-page":"131","volume-title":"Analysis of a protein kinase C-alpha mutation in human pituitary tumours","author":"Schiemann","year":"1997","journal-title":"J Endocrinol"},{"key":"key-10.4103\/0028-3886.205922-33","first-page":"25","volume-title":"Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C","author":"Alvaro","year":"1993","journal-title":"J Clin Endocrinol"},{"key":"key-10.4103\/0028-3886.205922-34","first-page":"851","volume-title":"Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas","author":"Murat","year":"2012","journal-title":"Brazilian J Med Biol Res"},{"key":"key-10.4103\/0028-3886.205922-35","doi-asserted-by":"publisher","unstructured":"Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, et al. (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304,554.","DOI":"10.1126\/science.1096502"},{"key":"key-10.4103\/0028-3886.205922-36","first-page":"301","volume-title":"Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors","author":"Lin","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"key-10.4103\/0028-3886.205922-37","first-page":"914","volume-title":"Ras mutations in human pituitary tumors","author":"Karga","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-38","first-page":"424","volume-title":"Ras, PI(3) K and mTOR signalling controls tumour cell growth","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"key-10.4103\/0028-3886.205922-39","first-page":"842","volume-title":"H-ras mutations in human pituitary carcinoma metastases","author":"Pei","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-40","first-page":"31","volume-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","author":"Reincke","year":"2014","journal-title":"Nat Genet"},{"key":"key-10.4103\/0028-3886.205922-41","first-page":"2","volume-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","author":"Normanno","year":"2006","journal-title":"Gene"},{"key":"key-10.4103\/0028-3886.205922-42","first-page":"M73","volume-title":"Decoding the genetic basis of Cushing's disease: USP8 in the spotlight","author":"Theodoropoulou","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0028-3886.205922-43","first-page":"E997","volume-title":"The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease","author":"Perez-Rivas","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-44","first-page":"306","volume-title":"Recurrent gain-of-function USP8 mutations in Cushing's disease","author":"Ma","year":"2015","journal-title":"Cell Res"},{"key":"key-10.4103\/0028-3886.205922-45","first-page":"4712","volume-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"key":"key-10.4103\/0028-3886.205922-46","first-page":"213","volume-title":"The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease","author":"Hayashi","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0028-3886.205922-47","first-page":"587","volume-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"key":"key-10.4103\/0028-3886.205922-48","first-page":"10914","volume-title":"Antioncogenes and human cancer","author":"Knudson","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0028-3886.205922-49","first-page":"22","volume-title":"Multiple endocrine neoplasia type 1 (MEN1): Analysis of 1336 mutations reported in the first decade following identification of the gene","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"key-10.4103\/0028-3886.205922-50","first-page":"484","volume-title":"Multiple endocrine neoplasia type 1: Clinical and genetic topics","author":"Marx","year":"1998","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0028-3886.205922-51","first-page":"43","volume-title":"Pituitary tumors in patients with MEN1 syndrome","author":"Syro","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"key-10.4103\/0028-3886.205922-52","first-page":"457","volume-title":"Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study","author":"Verg\u00e8s","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-53","first-page":"3288","volume-title":"Long-term natural course of pituitary tumors in patients with MEN1: Results from the Dutch MEN1 study group (DMSG)","author":"de","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-54","first-page":"19","volume-title":"p27 in cell cycle control and cancer","author":"M\u00f8ller","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"key-10.4103\/0028-3886.205922-55","first-page":"15558","volume-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0028-3886.205922-56","first-page":"2","volume-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"key-10.4103\/0028-3886.205922-57","first-page":"1826","volume-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-58","first-page":"5030","volume-title":"Novel genetic causes of pituitary adenomas","author":"Caimari","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0028-3886.205922-59","first-page":"1065","volume-title":"PRKACB and Carney complex","author":"Forlino","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.205922-60","first-page":"89","volume-title":"Mutations of the gene encoding the protein kinase A type I-[alpha] regulatory subunit in patients with the Carney complex","author":"Stratakis","year":"2000","journal-title":"Nat Genet"},{"key":"key-10.4103\/0028-3886.205922-61","first-page":"21","volume-title":"Carney complex (CNC)","author":"Bertherat","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"key-10.4103\/0028-3886.205922-62","first-page":"4041","volume-title":"Clinical and molecular features of the Carney complex: Diagnostic criteria and recommendations for patient evaluation","author":"Stratakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-63","first-page":"393","volume-title":"Succinate dehydrogenase-Assembly, regulation and role in human disease","author":"Rutter","year":"2010","journal-title":"Mitochondrion"},{"key":"key-10.4103\/0028-3886.205922-64","first-page":"33","volume-title":"Succinate dehydrogenase (SDHx) mutations in pituitary tumors: Could this be a new role for mitochondrial complex II and\/or Krebs cycle defects?","author":"Xekouki","year":"2012","journal-title":"Sect Endocrinol Genet"},{"key":"key-10.4103\/0028-3886.205922-65","first-page":"E531","volume-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: Results from a large patient cohort","author":"D\u00e9nes","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-66","first-page":"T105","volume-title":"15 years of paraganglioma: The association of pituitary adenomas and phaeochromocytomas or paragangliomas","author":"O'Toole","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"key-10.4103\/0028-3886.205922-67","doi-asserted-by":"publisher","unstructured":"Tufton N, Roncaroli, F Hadjidemetriou I, Dang M., Guasti L, D\u00e9nes J, Powell M, et al. Metastatic pituitary carcinoma in an SDHB mutation positive patient. Endocr Pathol 2016;7; DOI 10.1007\/s12022-017-9474-7.","DOI":"10.1007\/s12022-017-9474-7"},{"key":"key-10.4103\/0028-3886.205922-68","first-page":"560","volume-title":"Succinate dehydrogenase deficiency is rare in pituitary adenomas","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key-10.4103\/0028-3886.205922-69","first-page":"111","volume-title":"Pituitary blastoma: A pathognomonic feature of germ-line DICER1 mutations","author":"de","year":"2014","journal-title":"Acta Neuropathol"},{"key":"key-10.4103\/0028-3886.205922-70","first-page":"662","volume-title":"DICER1: Mutations, microRNAs and mechanisms","author":"Foulkes","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"key-10.4103\/0028-3886.205922-71","first-page":"239","volume-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","author":"Beckers","year":"2013","journal-title":"Endocr Rev"},{"key":"key-10.4103\/0028-3886.205922-72","first-page":"43","volume-title":"AIP mutation in pituitary adenomas in the 18th Century and today","author":"Chahal","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.205922-73","first-page":"78","volume-title":"Increased population risk of AIP-related acromegaly and gigantism in Ireland","author":"Radian","year":"2017","journal-title":"Hum Mutat"},{"key":"key-10.4103\/0028-3886.205922-74","first-page":"800","volume-title":"The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?","author":"Occhi","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"key-10.4103\/0028-3886.205922-75","first-page":"1973","volume-title":"AIP Mutation in Pituitary Adenomas","author":"Stals","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.205922-76","first-page":"402","volume-title":"AIP mutations in young patients with acromegaly and the Tampico giant: The Mexican experience","author":"Ram\u00edrez-Renter\u00eda","year":"2016","journal-title":"Endocrine"},{"key":"key-10.4103\/0028-3886.205922-77","first-page":"E1242","volume-title":"Landscape of familial isolated and young-onset pituitary adenomas: Prospective diagnosis in AIP mutation carriers","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-78","first-page":"39","volume-title":"Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53","author":"Kasuki","year":"2011","journal-title":"Neuroendocrinology"},{"key":"key-10.4103\/0028-3886.205922-79","first-page":"L25","volume-title":"AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression","author":"Kasuki","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"key-10.4103\/0028-3886.205922-80","first-page":"2363","volume-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","author":"Trivellin","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.205922-81","first-page":"353","volume-title":"X-linked acrogigantism syndrome: Clinical profile and therapeutic responses","author":"Beckers","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"key-10.4103\/0028-3886.205922-82","first-page":"745","volume-title":"Clinical and genetic characterization of pituitary gigantism: An international collaborative study in 208 patients","author":"Rostomyan","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"key-10.4103\/0028-3886.205922-83","first-page":"56","volume-title":"Germline or somatic GPR101 duplication leads to X-linked acrogigantism: A clinico-pathological and genetic study","author":"Iacovazzo","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"key-10.4103\/0028-3886.205922-84","doi-asserted-by":"publisher","unstructured":"Daly AF, Lysy PA, Desfilles C, Rostomyan L, Mohamed A, Caberg JH. (2016) GHRH excess and blockade in X-LAG syndrome. Endocrine-Related Cancer 23:161-170.","DOI":"10.1530\/ERC-15-0478"},{"key":"key-10.4103\/0028-3886.205922-85","first-page":"64","volume-title":"Gigantism: X-linked acrogigantism and GPR101 mutations","author":"Iacovazzo","year":"2016","journal-title":"Growth Horm IGF Res"},{"key":"key-10.4103\/0028-3886.205922-86","first-page":"817","volume-title":"McCune-Albright syndrome: A longitudinal clinical study of 32 patients.J Ped Endo Metabolism","author":"de","year":"1999","journal-title":""},{"key":"key-10.4103\/0028-3886.205922-87","first-page":"5104","volume-title":"Characterization of gsp -mediated growth hormone excess in the context of McCune-Albright syndrome","author":"Akintoye","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-88","first-page":"1955","volume-title":"Acromegaly and McCune-Albright syndrome","author":"Salenave","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0028-3886.205922-89","first-page":"221","volume-title":"Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects","author":"Daly","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"key-10.4103\/0028-3886.205922-90","first-page":"1927","volume-title":"Somatic GPR101 duplication causing X-linked acrogigantism (XLAG)-diagnosis and management","author":"Rodd","year":"2016","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:28:01Z","timestamp":1786714081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/neuroindia.NI_330_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"alternative-id":["205922"],"URL":"https:\/\/doi.org\/10.4103\/neuroindia.ni_330_17","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}